ASX Share rice
Sun 09 Aug 2020 - 07:13:pm (Sydney)

WLC Share Price


WLC Company Information


Wollongong Coal Limited


Basic Materials


Coking Coal

GIC Industry:

Metals & Mining

GIC Sub Industry:



7 Princes Highway 2518 Corrimal AUS


61 2 4223 6800

Company Overview:

Wollongong Coal Limited, together with its subsidiaries, engages in the mining of coal in Australia. It owns and operates the Russell Vale Colliery and the Wongawilli Colliery coal mines located in the Southern Coalfields region of New South Wales. The company was formerly known as Gujarat NRE Coking Coal Limited and changed its name to Wollongong Coal Limited in February 2014. Wollongong Coal Limited was incorporated in 2004 and is headquartered in Corrimal, Australia. Wollongong Coal Limited is a subsidiary of Jindal Steel & Power (Mauritius) Limited.

WLC Share Price Information

Dividend Yield:


WLC CashFlow Statement

CashFlow Date:


Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Inventory:


Change To Account Receivables:


Capital Expenditures:


WLC Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Income Tax Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


WLC Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:


Other Assets:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:




Accounts Payable:


WLC Share Price History

WLC News

10 Jul, 2020
Inventiva S.A. announced overnight Friday the pricing of its initial public offering at $14.40 per American depositary share, which was in the middle of the expected range, as the France-based biopharmaceutical company raised $107.7 million. The company sold 7.48 million ADS in the IPO, with each ADS representing one ordinary share. The IPO was expected to price between $13.40 and $15.40. The lead underwriters of the IPO were Jefferies, Stifel and Guggenheim Securities. The stock is expected to begin trading Friday on the Nasdaq, under the ticker symbol "IVA." The company is going public at a time that the Renaissance IPO ETF has run up 63.9% over the past three months, while the S&P 500 has gained 13.0%.